PI-273
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
925069-34-7
C02057-5mg
PI4K
PI3K/Akt/mTOR
CCC1=C (C) SC (=C1C (N) =O) NC (=S) NC (=O) C2=CC=C (Cl) C=C2
PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
3 years -20°C powder
Beschrijving
PI-273 Beschikbaar in 5 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Ligation Buffer
LB001
1.4 mL
BioCoupler® x 12
BC12
12 Each
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Recent gezochte producten
NIT2 Human qPCR Primer Pair (NM_020202)
HP213556
200 Reactions
NIT2 (NM_020202) Human Tagged ORF Clone
RC210660
10 µg
Human NIT2 (NM_020202) AAV Particle
RC210660A1V
250 µL
NIT2 (NM_020202) Human Tagged ORF Clone
RG210660
10 µg
NIT2 (NM_020202) Human Untagged Clone
SC108295
10 µg
NIT2 (NM_020202) Human 3' UTR Clone
SC204925
10 µg
LHX9 (NM_020204) Human 3' UTR Clone
SC210775
10 µg
Anti-h ST2 10202 SPTN-5
MBS5680565-01
1 mg